
Biophysical Therapeutics designs new drugs using computational biology, targeting cancer, aging diseases, and longevity.
Biophysical Therapeutics, founded by Dr. Michael Forrest, utilizes computational biology to design innovative drugs. The company's mission is to develop new treatments for cancer, aging diseases such as Alzheimer's, and to address aging itself, including its cosmetic implications. Their pipeline includes experimentally-validated drugs, both preclinical and repurposed clinical stage, aimed at longevity and disease mitigation.
Notable figures include founder Dr. Michael Forrest, a biochemist from Cambridge University. The company has achieved significant milestones, including the discovery of new fundamental biology and securing patents for their drug inventions. Biophysical Therapeutics' impact lies in its pioneering approach to drug design, potentially revolutionizing treatments for some of the most challenging health issues.

Regenerative Bio
regen-bio.us

BioAge Labs
bioagelabs.com

20n Bio
20n.bio

Biolexis Therapeutics
biolexistx.com

Cambrian BioPharma
cambrianbio.com

Rejuveron Life Sciences
rejuveron.com

Metaphore Biotechnologies
metaphorebio.com

Fountain Therapeutics
fountaintx.com

Biosim

ProFound Therapeutics
profoundtx.com

BioLeap

Persephone Biosciences

Retro Biosciences
retro.bio

Vilya
vilyatx.com

Juvenescence
juvlabs.com
Companies similar to Biophysical Therapeutics include Regenerative Bio, BioAge Labs, 20n Bio and Biolexis Therapeutics.
Biophysical Therapeutics was founded in 2022.
Biophysical Therapeutics' headquarters is located in Wilmington, DE, US.
Biophysical Therapeutics' most recent funding round was for $135k (USD) in June 2023.
As of Jun 5, 2023, Biophysical Therapeutics has raised a total of $135k (USD).
Biophysical Therapeutics has 6 employees as of Feb 5, 2024.